Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 3/20 | 0.93 |
| ▸ | CNR1 | P21554 | 3/20 | 0.93 |
| ▸ | CNR2 | P34972 | 3/20 | 0.93 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.93 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.93 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.93 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.93 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.93 |
| ▸ | TRPV3 | Q8NET8 | 2/20 | 0.93 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.93 |
| ▸ | TRPV2 | Q9Y5S1 | 2/20 | 0.93 |
| ▸ | LDHA | P00338 | 1/20 | 0.93 |
| ▸ | APP | P05067 | 2/20 | 0.63 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.59 |
| ▸ | HRH1 | P35367 | 1/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cannabichromene SCHEMBL29939768 | 0.97 | CNR1 (1.00) | SLC6A2CNR1CNR2TRPV1TRPA1 | |
| Cannabichromene SCHEMBL22095394 | 0.97 | CNR1 (1.00) | SLC6A2CNR1CNR2TRPV1TRPA1 | |
| Cannabichromene SCHEMBL22095415 | 0.97 | CNR1 (1.00) | SLC6A2CNR1CNR2TRPV1TRPA1 | |
| Cannabichromene SCHEMBL144938 | 0.97 | CNR1 (1.00) | SLC6A2CNR1CNR2TRPV1TRPA1 | |
| SCHEMBL29647739 | 0.95 | CNR1 (0.98) | SLC6A2CNR1CNR2TRPV1TRPA1 | |
| SCHEMBL25867685 | 0.95 | CNR1 (0.98) | SLC6A2CNR1CNR2TRPV1TRPA1 | |
| SCHEMBL21365703 | 0.93 | SLC6A2 (0.85) | SLC6A2CNR1CNR2TRPV1TRPA1 | |
| SCHEMBL22095688 | 0.93 | SLC6A2 (0.85) | SLC6A2CNR1CNR2TRPV1TRPA1 | |
| SCHEMBL21348201 | 0.93 | SLC6A2 (0.85) | SLC6A2CNR1CNR2TRPV1TRPA1 | |
| SCHEMBL31545108 | 0.93 | SLC6A2 (0.85) | SLC6A2CNR1CNR2TRPV1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250263761-A1 | PRODUCTION OF CANNABINOIDS/PHYTOCANNABINOIDS WITH A PLANT EXTRACT | Technische Universität Darmstadt (DE) | 2025-08-21 | — | — | US | disclosed |
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | KADDURAH DAOUK RIMA F (US) | 2023-11-23 | — | — | US | disclosed |
| EP-4244371-A1 | PRODUCTION OF CANNABINOIDS/PHYTOCANNABINOIDS WITH A PLANT EXTRACT | Technische Universität Darmstadt (DE) | 2023-09-20 | — | — | EP | disclosed |
| WO-2022101306-A1 | PRODUCTION OF CANNABINOIDS/PHYTOCANNABINOIDS WITH A PLANT EXTRACT | Technische Universität Darmstadt (DE) | 2022-05-19 | — | — | WO | disclosed |
| US-20220127213-A1 | METHOD FOR SELECTIVE SEPARATION, ISOLATION AND RECOVERY OF CANNABIDIOL AND CANNABIDIOL-LIKE MEROTERPENE ACIDS FROM COMPLEX MATRICES | NAHTIGAL ISTOK (CA) | 2022-04-28 | — | — | US | disclosed |
| WO-2022081350-A2 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | DUKE UNIVERSITY (US) | 2022-04-21 | — | — | WO | disclosed |
| US-20210289832-A1 | LIPOPHILIC ACTIVE AGENT INFUSED TOBACCO LEAVES AND/OR TOBACCO MATERIALS AND METHODS OF USE THEREOF | Poviva Corp. (US) | 2021-09-23 | — | — | US | disclosed |
| WO-2021163023-A1 | STABLE FORMULATIONS OF DRONABINOL | TRYAGx Labs Inc. (US) | 2021-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127213-A1 | METHOD FOR SELECTIVE SEPARATION, ISOLATION AND RECOVERY OF CANNABIDIOL AND CANNABIDIOL-LIKE MEROTERPENE ACIDS FROM COMPLEX MATRICES | CNR2, CNR1, AVPR1A | SLC6A2 2723/4885CNR1 2/4885CNR2 1/4885 |
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | SLC25A20, CPT2, NDUFAB1 | SLC6A2 361/4885CNR1 106/4885CNR2 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.